Seutic Labs Profile
Key Indicators
- Authorised Capital ₹ 4.15 Cr
as on 15-12-2024
- Paid Up Capital ₹ 4.15 Cr
as on 15-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 101.47 Cr
as on 15-12-2024
- Revenue 98.90%
(FY 2022)
- Profit -56.21%
(FY 2022)
- Ebitda -17.87%
(FY 2022)
- Net Worth 7.35%
(FY 2022)
- Total Assets 42.60%
(FY 2022)
About Seutic Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.15 Cr and a paid-up capital of Rs 4.15 Cr.
The company currently has active open charges totaling ₹101.47 Cr.
Venkata Valivarthi and Padma Valivarthi serve as directors at the Company.
- CIN/LLPIN
U24100TG2016PTC102893
- Company No.
102893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Seutic Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Valivarthi  | Director | 27-Jan-2016 | Current |
| Padma Valivarthi | Director | 27-Jan-2016 | Current |
Financial Performance of Seutic Labs.
Seutic Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 98.9% increase. The company also saw a substantial fall in profitability, with a 56.21% decrease in profit. The company's net worth moved up by a moderate rise of 7.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seutic Labs?
In 2021, Seutic Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seutic Pharma Private LimitedActive 10 years 5 monthsVenkata Valivarthi and Padma Valivarthi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Feb 2024 | ₹24.64 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 29 Sep 2022 | ₹10.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 29 Sep 2022 | ₹4.50 Cr | Open |
How Many Employees Work at Seutic Labs?
Seutic Labs has a workforce of 74 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seutic Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seutic Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
